Atlas Trials

Expanded Access for Treatment With Imetelstat

Clinical trial NCT05937568 · APPROVED_FOR_MARKETING

Trial details

NCT number
NCT05937568
Sponsor
Geron Corporation
Status
APPROVED_FOR_MARKETING
Study type
EXPANDED_ACCESS
Myelodysplastic Syndromes

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.